On 2 June 2014, the ABPI, the
BioIndustry Association (BIA) and the Centre for the Advancement of Sustainable
Medical Innovation (CASMI) jointly organised a stakeholder event in London to publicise
the EMA’s Adaptive Licensing pilot project.
This workshop allowed pharmaceutical and
biotech companies, as well as patient groups, to understand better which medicines would be appropriate to put forward for the Adaptive
Licensing pilot and to appreciate how the pilot would work in practice.